Navigation Links
Stiefel receives US FDA approval of Fabior™ Foam, 0.1%
Date:5/11/2012

edication to innovation, along with its focus on pharmaceutical, over-the-counter and aesthetic Dermatology products, has established Stiefel as a world leader in the skin health industry. To learn more about Stiefel, visit www.stiefel.com.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2011.

References

[1] American Academy of Dermatology. Acne: Who gets and causes. Available at http://www.aad.org/skin-conditions/dermatology-a-to-z/acne/who-gets-causes/acne-who-gets-and-causes. Accessed 26 April, 2012.

[2] US Department of Health and Human Services, National Institutes of Health, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Questions and Answers about Acne. October 2010. Available at http://www.niams.nih.gov/Health_Info/Acne/default.asp. Accessed 26 April, 2012.


'/>"/>
SOURCE GSK
Copyright©2010 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
2. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
3. RoundTable Healthcare Partners Names Charles W. Stiefel as Senior Advisor
4. Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
9. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013  Decision Resources, one of the world,s ... healthcare issues, finds that, for the treatment of ... European rheumatologists cite a therapy,s induction of remission ... their prescribing decisions. Over 60 percent and 70 ... the percentage of patients achieving remission at six ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a segment ... ), a leading global medical technology company, today announced the ... the latest in its line of high-performance research flow cytometers. ... high-performance multicolor analysis with the most compact footprint in its ... and a height of 30" (76.2 cm). Recognizing that space ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... Unprecedented amount of research reflects depth and breadth of, collaboration with investigators ... ... highlight impact of Zometa(R), the leading IV, bisphosphonate, on relapse rate of patients ... oral once-daily continuous, inhibitor of mTOR, including first results of RECORD-1 study in ...
... identify the, lipid core (fatty) coronary plaques of interest ... ... 15 InfraReDx, Inc. today,announced that physicians at Beaumont Hospital ... System in a patient,undergoing a cardiac catheterization. This is the ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
(Date:6/20/2013)... Volume based manufacturing savings have allowed Premier ... of both it's WHEY TOO GOOD Vanilla and WHEY ... Health’s whey protein shake drink mixes are ... to help maintain healthy blood sugar levels, increase energy, ... process. , Ideal for health conscious people interested ...
(Date:6/20/2013)... David Icke, the highly visible alternative researcher and speaker, ... , Fresh from the Bilderburg fringe festival and the Isle ... launch ‘The Peoples Voice’ TV and Radio station by the ... for journalists to cover the stories and investigations that the ... , Because this station is for the people, it ...
(Date:6/20/2013)... CT (PRWEB) June 20, 2013 Startups ... to energize their sales or test new markets, and ... U.S. now have a new sales outsourcing ... sustained sales revenue. , Strategy Sales Partners ... professionals. Founded by business owners for business owners, Strategy ...
(Date:6/20/2013)... The University of Saint Mary is ... online Master of Science in Nursing (MSN) program ... Nursing from the American Association of Colleges of Nursing ... most major nursing master’s degree programs nationwide. , The ... University of Saint Mary not only delivers the most ...
(Date:6/19/2013)... 2013 Paleo Burn has finally been released ... sculpt the body they desire with no fad diets, pills, ... and health food products, Ken Smith was bold enough to ... an easy, automatic, and permanent solution for weight loss. ... , After a quick review of Paleo Burn, TotalWellnessCleanse.net believes ...
Breaking Medicine News(10 mins):Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 2Health News:Premier Natural Health, a Leading Provider of Natural Food Products and Herbal Solutions, Reduces Prices On Its Popular Whey Protein Product 3Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3Health News:University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials 2Health News:University of Saint Mary Launches New Online Master of Science in Nursing Built on the Latest AACN Essentials 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2
... KIRKLAND, Wash., Nov. 16 CellCyte Genetics,Corporation ... appointed Tony,Colasin as its Director of Business ... technology licensing efforts. Tony Colasin was ... ICOS,Corporation. From January 2001 to January 2007, ...
... following is being,issued by the National Council on Disability:, ... to December 1, 2007., WHERE:, Hyatt Regency Boston ... November 29, 2007, 8:30 a.m. - 10:00 a.m. ... Vaughn -- Introduction of Council Members, NCD staff and ...
... an agreement with the International Sports Engineering Association (ISEA) ... by the ISEA, Sports Engineering is in its 10th ... will appear in January 2008. , Sports Engineering publishes ... to sport. The quarterly journal fills the niche ...
... Improvements in child wellbeing in rich countries might depend more ... according to a study published today on bmj.com . ... in each society. But a recent UNICEF report detailing ... and the USA fared worse than in any of the ...
... Cancer Research Center ... in January, ... Award(R), which is given annually to a Major League,Baseball player who best ... on and off the field. Sweeney, a player for the Kansas ...
... Stop ... Tenn., Nov. 15 Stanford Financial Group CFO,James M. Davis and ... St. Jude and Laurie Tucker, Senior Vice President of Corporate,Marketing with ... St. Jude Championship. The donation from the 2007 event,held this past ...
Cached Medicine News:Health News:CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development 2Health News:CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development 3Health News:CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development 4Health News:National Council on Disability (NCD) Hosts Quarterly Meeting 2Health News:National Council on Disability (NCD) Hosts Quarterly Meeting 3Health News:Springer to publish Sports Engineering 2Health News:Low standards of child well-being linked to greater income inequality 2Health News:Mike Sweeney Named 2007 Hutch Award Winner 2Health News:Stanford St. Jude Championship Presents $1.76 Million Donation To St. Jude Children's Research Hospital(R) 2Health News:Stanford St. Jude Championship Presents $1.76 Million Donation To St. Jude Children's Research Hospital(R) 3Health News:Stanford St. Jude Championship Presents $1.76 Million Donation To St. Jude Children's Research Hospital(R) 4
... The Akbarnia PDR Instruments ... surgeons negotiate in and around ... and reconstruction procedures. The instruments ... construction, a variety of angled ...
... consisting of 38 cobbs, osteotomes, elevators, ... spine. The instruments extra (15) length ... best applied in thoracic, lumbar and ... for surgeons to pick and choose ...
... Autologous growth factors (AGF) technology. ... the AGF gel delivers a ... factors and proteins in high ... information of new bone cells ...
With the Leica D2D V3 video and photography system you can produce fantastic digital videos and pictures with the highest resolution....
Medicine Products: